Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Case of Hepatocellular Carcinoma Successfully Resumed Atezolizumab and Bevacizumab After Associated Grade 3 Diarrhea and Grade 2 Colitis: Case Report and Literature Review.
Fuji T, Arai J, Otoyama Y, Nio Y, Sugiura I, Nakajima Y, Kajiwara A, Ichikawa Y, Uozumi S, Shimozuma Y, Uchikoshi M, Sakaki M, Nozawa H, Momo K, Sasaki T, Yoshida H. Fuji T, et al. Among authors: uozumi s. Onco Targets Ther. 2022 Oct 25;15:1281-1288. doi: 10.2147/OTT.S383769. eCollection 2022. Onco Targets Ther. 2022. PMID: 36303951 Free PMC article.
Muscular Metastasis of Hepatocellular Carcinoma: Case Report and Literature Review.
Nakayama A, Arai J, Otoyama Y, Sugiura I, Nakajima Y, Kajiwara A, Ichikawa Y, Uozumi S, Shimozuma Y, Uchikoshi M, Sakaki M, Tazawa S, Shiozawa E, Yamochi T, Takimoto M, Yoshida H. Nakayama A, et al. Among authors: uozumi s. Intern Med. 2022 Jan 15;61(2):189-196. doi: 10.2169/internalmedicine.7200-21. Epub 2021 Jul 3. Intern Med. 2022. PMID: 34219106 Free PMC article. Review.
Three cases of histologically proven hepatic epithelioid hemangioendothelioma evaluated using a second-generation microbubble contrast medium in ultrasonography: case reports.
Arai J, Shimozuma Y, Otoyama Y, Sugiura I, Nakajima Y, Hayashi E, Kajiwara A, Omori R, Uozumi S, Miyashita M, Uchikoshi M, Doi H, Sakaki M, Wang T, Eguchi J, Ito T, Kurihara T, Munechika J, Gokan T, Saito K, Miura S, Tate G, Takimoto M, Yoshida H. Arai J, et al. Among authors: uozumi s. BMC Gastroenterol. 2019 Nov 14;19(1):187. doi: 10.1186/s12876-019-1113-y. BMC Gastroenterol. 2019. PMID: 31727083 Free PMC article.
Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding.
Arai J, Goto K, Otoyama Y, Nakajima Y, Sugiura I, Kajiwara A, Tojo M, Ichikawa Y, Uozumi S, Shimozuma Y, Uchikoshi M, Sakaki M, Nozawa H, Nakagawa R, Muroyama R, Kato N, Yoshida H. Arai J, et al. Among authors: uozumi s. Cancer Immunol Immunother. 2021 Jan;70(1):203-213. doi: 10.1007/s00262-020-02660-2. Epub 2020 Jul 18. Cancer Immunol Immunother. 2021. PMID: 32683508 Free PMC article.
Laparoscopic Treatment of a Hepatoduodenal Ligament Schwannoma With Infrared Indocyanine Green Fluorescence.
Tomioka K, Aoki T, Koizumi T, Elewa A, Kusano T, Matsuda K, Nogaki K, Tashiro Y, Wada Y, Hakozaki T, Shibata H, Hirai T, Yamazaki T, Saito K, Enami Y, Sugiura I, Nakajima Y, Arai J, Kajiwara A, Uozumi S, Shimozuma YU, Uchikoshi M, Sakaki M, Yoshida H, Miura S, Murakami M. Tomioka K, et al. Among authors: uozumi s. In Vivo. 2020 Jul-Aug;34(4):2037-2041. doi: 10.21873/invivo.12004. In Vivo. 2020. PMID: 32606179 Free PMC article.
Decreased expression of interferon-stimulated genes in B cells of patients with chronic hepatitis C during interferon-free therapy potentially suggests the eradication of hepatitis C virus in the B cells: A cohort study.
Arai J, Ito T, Shimozuma Y, Uchikoshi M, Nakajima Y, Sakaki M, Uozumi S, Kajiwara A, Sugiura I, Otoyama Y, Nozawa H, Kurihara T, Eguchi J, Nomura N, Sakuma D, Sato M, Deguchi Y, Yoshida H. Arai J, et al. Among authors: uozumi s. Health Sci Rep. 2020 Jul 15;3(3):e176. doi: 10.1002/hsr2.176. eCollection 2020 Sep. Health Sci Rep. 2020. PMID: 32685701 Free PMC article.
Strong CD8(+) T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma.
Hiroishi K, Eguchi J, Baba T, Shimazaki T, Ishii S, Hiraide A, Sakaki M, Doi H, Uozumi S, Omori R, Matsumura T, Yanagawa T, Ito T, Imawari M. Hiroishi K, et al. Among authors: uozumi s. J Gastroenterol. 2010 Apr;45(4):451-8. doi: 10.1007/s00535-009-0155-2. Epub 2009 Nov 20. J Gastroenterol. 2010. PMID: 19936602
195 results